- Home
- MURA vs FOA Comparison
MURA vs FOA Comparison
Compare MURA & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- FOA
- Stock Information
- Founded
- MURA 2013
- FOA 2013
- Country
- MURA Ireland
- FOA United States
- Employees
- MURA N/A
- FOA N/A
- Industry
- MURA
- FOA Finance Companies
- Sector
- MURA
- FOA Finance
- Exchange
- MURA Nasdaq
- FOA Nasdaq
- Market Cap
- MURA 55.5M
- FOA 78.3M
- IPO Year
- MURA N/A
- FOA N/A
- Fundamental
- Price
- MURA $3.15
- FOA $10.18
- Analyst Decision
- MURA Strong Buy
- FOA Strong Buy
- Analyst Count
- MURA 2
- FOA 2
- Target Price
- MURA $14.00
- FOA $17.00
- AVG Volume (30 Days)
- MURA 78.9K
- FOA 33.2K
- Earning Date
- MURA 08-13-2024
- FOA 11-05-2024
- Dividend Yield
- MURA N/A
- FOA N/A
- EPS Growth
- MURA N/A
- FOA N/A
- EPS
- MURA N/A
- FOA N/A
- Revenue
- MURA N/A
- FOA $359,013,000.00
- Revenue This Year
- MURA N/A
- FOA N/A
- Revenue Next Year
- MURA N/A
- FOA N/A
- P/E Ratio
- MURA N/A
- FOA $7.83
- Revenue Growth
- MURA N/A
- FOA 540.89
- 52 Week Low
- MURA $2.88
- FOA $4.10
- 52 Week High
- MURA $6.25
- FOA $16.00
- Technical
- Relative Strength Index (RSI)
- MURA 44.69
- FOA 83.52
- Support Level
- MURA $3.06
- FOA $7.02
- Resistance Level
- MURA $3.55
- FOA $7.24
- Average True Range (ATR)
- MURA 0.17
- FOA 0.54
- MACD
- MURA -0.01
- FOA 0.28
- Stochastic Oscillator
- MURA 27.27
- FOA 60.71
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to an range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.